Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Dry Eye Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02843659
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Bristol-Myers Squibb 45
Not applicableStudy completedNCT05965778
What this trial is testing

Performance and Safety of T2769 in DED

Who this might be right for
Dry Eye
Laboratoires Thea 251
Not applicableEnded earlyNCT05053789
What this trial is testing

Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease

Who this might be right for
Eye Diseases
Vienna Institute for Research in Ocular Surgery 48
Large-scale testing (Phase 3)Study completedNCT02455050
What this trial is testing

Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Who this might be right for
Dry Eye Syndromes
Allergan 79
Testing effectiveness (Phase 2)WithdrawnNCT05217472
What this trial is testing

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Who this might be right for
Sjogren's Syndrome (SS)
AbbVie
Large-scale testing (Phase 3)Looking for participantsNCT06766357
What this trial is testing

The Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

Who this might be right for
Moderate to Severe Dry Eye
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT05745064
What this trial is testing

TL-925 as a Treatment for Dry Eye Disease

Who this might be right for
Dry Eye Disease
Telios Pharma, Inc. 107
Testing effectiveness (Phase 2)Study completedNCT06780306
What this trial is testing

A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

Who this might be right for
Dry EyeDry Eye Disease (DED)Dry Eye Disease With Severe Keratitis
BioTissue Holdings, Inc 74
Large-scale testing (Phase 3)Study completedNCT03833388
What this trial is testing

Study of TOP1630 for Dry Eye Syndrome

Who this might be right for
Dry Eye Syndrome
Topivert Pharma Ltd 202
Testing effectiveness (Phase 2)Ended earlyNCT04035668
What this trial is testing

Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome

Who this might be right for
Sjögren Syndrome
Novartis Pharmaceuticals 73
Large-scale testing (Phase 3)Study completedNCT01568593
What this trial is testing

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Who this might be right for
Dry Eye Syndromes
Laboratoires Thea 93
Large-scale testing (Phase 3)Study completedNCT02023268
What this trial is testing

Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome

Who this might be right for
Dry Eye Syndrome
Laboratoires Thea 105
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836660
What this trial is testing

IBI355 in Participants With Moderate-to-Severe Sjögren's Disease

Who this might be right for
Sjögren's Disease
Innovent Biologics (Suzhou) Co. Ltd. 198
Early research (Phase 1)Looking for participantsNCT07041099
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Who this might be right for
SjögrenSjogren DiseaseSjogren's Syndrome
Cullinan Therapeutics Inc. 36
Post-approval studies (Phase 4)Study completedNCT00818909
What this trial is testing

Systane Clinical Experience Study

Who this might be right for
Dry Eye Syndrome
Alcon Research 941
Large-scale testing (Phase 3)Study completedNCT03108664
What this trial is testing

HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)

Who this might be right for
Dry Eye Disease
Sylentis, S.A. 330
Post-approval studies (Phase 4)Active Not RecruitingNCT06947850
What this trial is testing

DOMPE -MT Neurotrophic Keratitis

Who this might be right for
Dry EyeNeurotrophic Keratitis
Toyos Clinic 10
Large-scale testing (Phase 3)Study completedNCT01804361
What this trial is testing

Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes

Who this might be right for
Dry Eye Syndromes
DH Bio Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT06104124
What this trial is testing

Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Who this might be right for
Sjogren's Syndrome
Amgen 651
Not applicableUnknownNCT03645850
What this trial is testing

Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness

Who this might be right for
Dry Eye
Horus Pharma 80
Next Page